Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.
Martin Sattler, James D Griffin, Sebastien Letard, Patrice Dubreuil, Sophia Adamia, Richard M Stone, Nathanael Gray, Jinhua Wang, Jing Yang, Xiaoxi Liu, Sara J Buhrlage, Prafulla C Gokhale, Hong L Tiv, Abigail E Case, Chengcheng Meng, Ellen Weisberg
British journal of haematology 2020;187(4):488-501